Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

The Effectiveness of Transcranial Magnetic Stimulation and Mirror Therapy in Hemispatial Neglect

Evaluation of the Effectiveness of Transcranial Magnetic Stimulation and Mirror Therapy in Hemispatial Neglect Developing After Stroke

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The aim of this study is to evaluate the effectiveness of continuous Theta Burst Stimulation added to mirror therapy on neglect associated with stroke.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Ischemic/haemorrhagic stroke 2. Right hemisphere lesion 3. Patients with a duration of more than 7 days but less than 1 year from the date of the event 4. Aged between 18 and 75 years 5. Patients with a Mini Mental Test Score ≥ 24 Who Should NOT Join This Trial: 1. History of recurrent stroke 2. Presence of vision or hearing problems 3. Use of medication affecting cognitive function 4. History of epilepsy 5. Pregnancy or breastfeeding 6. History of malignancy 7. Pacemaker 8. Presence of metallic implants in the brain or scalp (including cochlear implant) 9. History of premorbid dementia 10. Presence of psychiatric or additional neurological disease Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Ischemic/haemorrhagic stroke 2. Right hemisphere lesion 3. Patients with a duration of more than 7 days but less than 1 year from the date of the event 4. Aged between 18 and 75 years 5. Patients with a Mini Mental Test Score ≥ 24 Exclusion Criteria: 1. History of recurrent stroke 2. Presence of vision or hearing problems 3. Use of medication affecting cognitive function 4. History of epilepsy 5. Pregnancy or breastfeeding 6. History of malignancy 7. Pacemaker 8. Presence of metallic implants in the brain or scalp (including cochlear implant) 9. History of premorbid dementia 10. Presence of psychiatric or additional neurological disease

Treatments Being Tested

OTHER

Mirror Therapy

Mirror therapy will be administered 5 days a week for 2 weeks.

DEVICE

cTBS

Patients received cTBS applied to the P3 region according to the 10/20 electroencephalogram system for 5 days a week, totalling 10 sessions over 2 weeks.

OTHER

Cognitive rehabilitation

Methods that facilitate adaptation in daily life activities will be taught.

Locations (1)

Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)